Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Preserving livers at body temperature may improve transplant outcomes and increase viable donor liver numbers, thereby lowering waiting list mortality rates, reports a paper published online this week in Nature.

The current supply of viable donor livers isn’t enough to meet the demand caused by rising liver disease rates. The way we store donor livers today – in cold storage – means many livers must be discarded. The Consortium for Organ Preservation in Europe (COPE) clinical trial team at the Nuffield Department of Surgical Sciences, supported by CSM statistician Susan Dutton, tested whether maintaining livers at body temperature would mean fewer livers are discarded - so that more transplants can be carried out - and whether patients do better after transplant. The results were published online this week in Nature.

 

This research has the potential to profoundly improve liver transplants globally. - Dr David Nasralla

Many potential donor livers are deemed too high risk, because they are more susceptible to damage during the refrigeration used to preserve organs during transport between where the liver is donated and where the potential recipient is. Once a liver is in cold storage, normal cellular activity is suppressed, so we can’t test the liver’s viability until it has been transplanted and warmed up again. Instead, we could keep donor livers at body temperature and give them oxygenated blood, medication, and nutrients, as if they were on life support, using a process called normothermic machine perfusion. Livers can be kept like this for up to 24 hours. The process could one day allow us to monitor viability and even treat and repair the livers if needed.

David Nasralla and colleagues conducted the first randomized trial comparing conventional cold storage with normothermic machine perfusion in 220 liver transplant patients. They measured biomarkers of liver damage and found a 50% drop in graft injury and a 50% lower rate of organ discard when normothermic preservation was used instead of cold storage, even though the livers were preserved for 54% longer before transplant. In the year after transplant, the team found no significant differences in rates of bile duct complication, or graft and patient survival rates (as predicted by a clinically accepted biomarkers) between the different preservation approaches. "This research has the potential to profoundly improve liver transplants globally," says Dr Nasralla.

The device used for normothermic machine preservation was developed by OrganOx Ltd, a MedTech business spun-out from the University of Oxford as a result of a collaboration between Peter Friend (Nuffield Department of Surgical Sciences) and Constantin Coussios (Institute of Biomedical Engineering).

“It has been a while since proper innovation boosted organ transplantation,” writes Stefan Schneeberger in an accompanying Nature News & Views article. He explains that normothermic machine perfusion may substantially increase viable donor organ numbers and allow more time for transplants to occur.

Read more news coverage about this study on BBC Health News and University of Oxford News.

COPE is funded by a European Commission FP7 Award and is the official organ preservation task force of the European Society for Organ Transplantation (ESOT).

Similar stories

NIHR Fellowships awarded to NDORMS researchers

Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships

ORUK Early Career Research Fellowship awarded to NDORMS researcher

Congratulations to Jack Tu who has been awarded an Orthopaedic Research UK Early Career Research Fellowship to explore the cause of knee pain after total knee replacement.

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report

Unhelpful thoughts about fracture symptoms hinder recovery

The importance of mindsets and feelings about fracture symptoms have been shown to be a key factor in recovery of musculoskeletal conditions.

Fat tissues can play a protective role against inflammation in the intestine

A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.

NDORMS researchers awarded Sir Henry Wellcome Fellowships

Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.